DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
DALS was delisted on the 28th of July, 2023.
0 hedge funds and large institutions have $0 invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 50 closing their positions.
100% less funds holding
Funds holding: 50 → 0 (-50)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $177M → $0 (-$177M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 50
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$24.2M |
| 2 |
DM
Deerfield Management
New York
|
-$16.4M |
| 3 |
BlackRock
New York
|
-$15.4M |
| 4 |
SCM
Saba Capital Management
New York
|
-$12.7M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$12.1M |
DALS Hedge Fund Activity: Q3 2023 in Review
0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q3 2023, worth a combined $0 — down 100% from $177M a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of DALS and 0 opened new positions — a net loss of 50 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was First Trust Capital Management, exiting entirely with an estimated $24.2M sold.
- 0 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q3 2023, down from 50 in Q2 2023.
- Funds reported $0 of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q3 2023 and 50 closed out, a net change of -50 holders.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q3 2023 was First Trust Capital Management, an estimated $24.2M sold.
Based on aggregated 13F filings for Q3 2023.